Hydromorphone Hydrochloride

盐酸氢吗啡酮

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameHydromorphone Hydrochloride
Drug Alias Namehidromorfona氢吗啡酮Hydromorphone extended release二氢吗啡酮的盐酸盐氢化吗啡酮 +[29] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsPain, ProceduralLabor PainChronic Pain +[12] 
Global Approved IndicationsPain
Approved Indications in ChinaPain
Original Approved Country/TerritoryUnited States
Original Approved Date1984/01/11
Country/TerritoryCzechiaCanadaUnited States +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesQinghai Red Cross HospitalNapp Pharmaceuticals LtdThe University Of Iowa +[7] 
Inactive CompaniesJanssen-Cilag International NvRoswell Park Cancer InstitutePurdue Pharma Lp +[14] 
Active IndicationsPain, ProceduralCancer PainPain
Inactive IndicationsLabor PainChronic PainLow Back Pain +[9] 

Other Information

ATC CodeN02AA03
Related LinksWikipediaDrugBankKEGG